Your browser doesn't support javascript.
loading
Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer.
den Uil, Sjoerd H; de Wit, Meike; Slebos, Robbert J C; Delis-van Diemen, Pien M; Sanders, Joyce; Piersma, Sander R; Pham, Thang V; Coupé, Veerle M H; Bril, Herman; Stockmann, Hein B A C; Jimenez, Connie R; Meijer, Gerrit A; Fijneman, Remond J A.
Afiliación
  • den Uil SH; Department of Surgery, Spaarne Gasthuis, Boerhaavelaan 22, 2035 RC, Haarlem, the Netherlands.
  • de Wit M; Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.
  • Slebos RJC; Department of Head & Neck Oncology and Endocrinology, Clinical Science Laboratory, Moffitt Cancer Center, 13131 Magnolia Drive, Tampa, FL, 33612, USA.
  • Delis-van Diemen PM; Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.
  • Sanders J; Department of Pathology, Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.
  • Piersma SR; Department of Medical Oncology, OncoProteomics Laboratory, Amsterdam UMC, VU University Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands.
  • Pham TV; Department of Medical Oncology, OncoProteomics Laboratory, Amsterdam UMC, VU University Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands.
  • Coupé VMH; Department of Epidemiology and Biostatistics, Amsterdam UMC, VU University Medical Center, de Boelelaan 1089a, 1081 HV, Amsterdam, the Netherlands.
  • Bril H; Department of Pathology, Spaarne Gasthuis, Boerhaavelaan 22, 2035 RC, Haarlem, the Netherlands.
  • Stockmann HBAC; Department of Surgery, Spaarne Gasthuis, Boerhaavelaan 22, 2035 RC, Haarlem, the Netherlands.
  • Jimenez CR; Department of Medical Oncology, OncoProteomics Laboratory, Amsterdam UMC, VU University Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands.
  • Meijer GA; Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.
  • Fijneman RJA; Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands. Electronic address: r.fijneman@nki.nl.
Eur J Cancer ; 144: 91-100, 2021 02.
Article en En | MEDLINE | ID: mdl-33341450
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Colectomía / Neoplasias del Colon / Factor de Transcripción CDX2 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Colectomía / Neoplasias del Colon / Factor de Transcripción CDX2 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article